Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new drug for people with symptomatic knee osteoarthritis to see if it is effective, safe, and tolerable.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had knee pain most days in the last 3 months, rated between 5 to 9.My knee pain score is 60 or less.My knee MRI shows I have moderate to severe inflammation.My knee pain score is 60 or less.I have had knee pain rated between 5 to 9 for most days in the last 3 months.My knee X-ray shows moderate to severe arthritis.I have had moderate to severe knee pain most days in the last 3 months.I have had knee pain most days in the last 3 months, rated between 5 to 9.I do not have active infections like HIV or chronic hepatitis B or C.I have not taken any prohibited medications recently.I have an autoimmune or joint disease, or an infection in my knee.I am between 50 and 80 years old.My knee MRI shows active inflammation in the joint.My knee is severely misaligned by more than 7.5 degrees.I weigh at least 50 kg and my BMI is between 18 and 35.My knee MRI shows I have moderate to severe inflammation.I weigh at least 50 kg and my BMI is between 18 and 35.My knee X-ray shows moderate to severe arthritis.I am between 50 and 80 years old.I'm sorry, but "Key" is not a screening criterion. It's unclear what you are referring to. Please provide more context or information.My knee pain score is 60 or less.My knee X-ray shows moderate to severe arthritis.
- Group 1: DFV890
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How can I become part of this medical research?
"This clinical trial is accepting candidates between the ages of 50 and 80, who are suffering from osteoarthritis in their knee. Around 108 individuals will be selected for participation."
To what extent has recruitment expanded for this trial?
"Affirmative, clinicaltrials.gov confirms that recruitment is ongoing for this trial which was first listed on September 20th 2021. The latest update to the listing occurred November 21st 2022 and the team needs to enlist 108 patients from 8 different medical facilities."
Is this experiment accepting new participants at the moment?
"Affirmative, clinicaltrials.gov corroborates that this research trial is actively seeking patients. Originally posted on September 20th 2021, it was recently updated on November 21st 2022 and requires 108 participants from 8 distinct sites."
Has DFV890 received clearance by the Food and Drug Administration?
"While there is preliminary data suggesting the safety of DFV890, efficacy has yet to be tested. Consequently, our team at Power rated it a 2 on a scale from 1-3."
What is the number of healthcare institutions conducting this experiment?
"At present, this medical trial is being conducted in 8 different sites. These locations span from Plantation to Miami Lakes and Chicago with many other places in between. If you are looking to participate, it is best to choose the nearest centre so as not to burden yourself with excessive travel."
Is this trial available for those over the age of 40?
"This experiment is only open to individuals between 50 and 80 years of age. There are 38 trials catering to youths below 18, while 656 studies cater to the elderly population above 65."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Novartis Investigative Site: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger